PubMed registered articles

Ola Myklebost

Publications published since 1983 by Ola Myklebost

154 publications found

Publications 2017

  1. Behjati S, Tarpey PS, Haase K, Ye H, Young MD, Alexandrov LB, Farndon SJ, Collord G, Wedge DC, Martincorena I, Cooke SL, Davies H, Mifsud W, Lidgren M, Martin S, Latimer C, Maddison M, Butler AP, Teague JW, Pillay N, Shlien A, McDermott U, Futreal PA, Baumhoer D, Zaikova O et al. (2017)
    Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma
    Nat Commun, 8, 15936
    PubMed 28643781
  2. Berg KCG, Eide PW, Eilertsen IA, Johannessen B, Bruun J, Danielsen SA, Bjørnslett M, Meza-Zepeda LA, Eknæs M, Lind GE, Myklebost O, Skotheim RI, Sveen A, Lothe RA (2017)
    Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies
    Mol Cancer, 16 (1), 116
    PubMed 28683746
  3. Helland Å, Brustugun OT, Nakken S, Halvorsen AR, Dønnem T, Bremnes R, Busund LT, Sun J, Lorenz S, Solberg SK, Jørgensen LH, Vodak D, Myklebost O, Hovig E, Meza-Zepeda LA (2017)
    High number of kinome-mutations in non-small cell lung cancer is associated with reduced immune response and poor relapse-free survival
    Int J Cancer, 141 (1), 184-190
    PubMed 28387924
  4. Namløs HM, Zaikova O, Bjerkehagen B, Vodák D, Hovig E, Myklebost O, Boye K, Meza-Zepeda LA (2017)
    Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report
    BMC Cancer, 17 (1), 29
    PubMed 28061772
  5. Rustad EH, Coward E, Skytøen ER, Misund K, Holien T, Standal T, Børset M, Beisvag V, Myklebost O, Meza-Zepeda LA, Dai HY, Sundan A, Waage A (2017)
    Monitoring multiple myeloma by quantification of recurrent mutations in serum
    Haematologica, 102 (7), 1266-1272
    PubMed 28385781
  6. Serguienko A, Hanes R, Grad I, Wang MY, Myklebost O, Munthe E (2017)
    PP2A regulatory subunit B55γ is a gatekeeper of osteoblast maturation and lineage maintenance
    Stem Cells Dev (in press)
    PubMed 28805158
  7. Sveen A, Johannessen B, Tengs T, Danielsen SA, Eilertsen IA, Lind GE, Berg KCG, Leithe E, Meza-Zepeda LA, Domingo E, Myklebost O, Kerr D, Tomlinson I, Nesbakken A, Skotheim RI, Lothe RA (2017)
    Multilevel genomics of colorectal cancers with microsatellite instability-clinical impact of JAK1 mutations and consensus molecular subtype 1
    Genome Med, 9 (1), 46
    PubMed 28539123

Publications 2016

  1. Ballinger ML, Goode DL, Ray-Coquard I, James PA, Mitchell G, Niedermayr E, Puri A, Schiffman JD, Dite GS, Cipponi A, Maki RG, Brohl AS, Myklebost O, Stratford EW, Lorenz S, Ahn SM, Ahn JH, Kim JE, Shanley S, Beshay V, Randall RL, Judson I, Seddon B, Campbell IG, Young MA et al. (2016)
    Monogenic and polygenic determinants of sarcoma risk: an international genetic study
    Lancet Oncol, 17 (9), 1261-71
    PubMed 27498913
  2. Barøy T, Chilamakuri CS, Lorenz S, Sun J, Bruland ØS, Myklebost O, Meza-Zepeda LA (2016)
    Genome Analysis of Osteosarcoma Progression Samples Identifies FGFR1 Overexpression as a Potential Treatment Target and CHM as a Candidate Tumor Suppressor Gene
    PLoS One, 11 (9), e0163859
    PubMed 27685995
  3. Halvorsen AR, Silwal-Pandit L, Meza-Zepeda LA, Vodak D, Vu P, Sagerup C, Hovig E, Myklebost O, Børresen-Dale AL, Brustugun OT, Helland Å (2016)
    TP53 Mutation Spectrum in Smokers and Never Smoking Lung Cancer Patients
    Front Genet, 7, 85
    PubMed 27242894
  4. Hanes R, Grad I, Lorenz S, Stratford EW, Munthe E, Reddy CC, Meza-Zepeda LA, Myklebost O (2016)
    Preclinical evaluation of potential therapeutic targets in dedifferentiated liposarcoma
    Oncotarget, 7 (34), 54583-54595
    PubMed 27409346
  5. Ju YS, Tubio JM, Mifsud W, Fu B, Davies HR, Ramakrishna M, Li Y, Yates L, Gundem G, Tarpey PS, Behjati S, Papaemmanuil E, Martin S, Fullam A, Gerstung M, ICGC Prostate Cancer Working Group, ICGC Bone Cancer Working Group, ICGC Breast Cancer Working Group, Nangalia J, Green AR, Caldas C, Borg Å, Tutt A, Lee MT, Van't Veer LJ et al. (2016)
    Corrigendum: Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells
    Genome Res, 26 (5), 717.2
    PubMed 27197245
  6. Lorenz S, Barøy T, Sun J, Nome T, Vodák D, Bryne JC, Håkelien AM, Fernandez-Cuesta L, Möhlendick B, Rieder H, Szuhai K, Zaikova O, Ahlquist TC, Thomassen GO, Skotheim RI, Lothe RA, Tarpey PS, Campbell P, Flanagan A, Myklebost O, Meza-Zepeda LA (2016)
    Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrations
    Oncotarget, 7 (5), 5273-88
    PubMed 26672768
  7. Safavi S, Järnum S, Vannas C, Udhane S, Jonasson E, Tomic TT, Grundevik P, Fagman H, Hansson M, Kalender Z, Jauhiainen A, Dolatabadi S, Stratford EW, Myklebost O, Eriksson M, Stenman G, Schneider-Stock R, Ståhlberg A, Åman P (2016)
    HSP90 inhibition blocks ERBB3 and RET phosphorylation in myxoid/round cell liposarcoma and causes massive cell death in vitro and in vivo
    Oncotarget, 7 (1), 433-45
    PubMed 26595521
  8. Sandhu V, Wedge DC, Bowitz Lothe IM, Labori KJ, Dentro SC, Buanes T, Skrede ML, Dalsgaard AM, Munthe E, Myklebost O, Lingjærde OC, Børresen-Dale AL, Ikdahl T, Van Loo P, Nord S, Kure EH (2016)
    The Genomic Landscape of Pancreatic and Periampullary Adenocarcinoma
    Cancer Res, 76 (17), 5092-102
    PubMed 27488532
  9. Whelan J, Dirksen U, Hassan B, Anninga J, Bennister L, Bovée JVMG, Brennan B, Broto JM, Brugières L, Cleton-Jansen AM, Copland C, Dutour A, Fagioli F, Ferrari S, Fiocco M, Fleuren E, Gaspar N, Gelderblom H, Gerrand C, Gerß J, Gonzato O, van der Graaf W, Hecker-Nolting S, Herrero-Martín D, Klco-Brosius S et al. (2016)
    The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24-25, 2015. Workshop Report
    Clin Sarcoma Res, 6, 3
    PubMed 27315524

Publications 2015

  1. Budin-Ljøsne I, Bentzen HB, Solbakk JH, Myklebost O (2015)
    Genome sequencing in research requires a new approach to consent
    Tidsskr Nor Laegeforen, 135 (22), 2031-2
    PubMed 26627287
  2. Ju YS, Tubio JM, Mifsud W, Fu B, Davies HR, Ramakrishna M, Li Y, Yates L, Gundem G, Tarpey PS, Behjati S, Papaemmanuil E, Martin S, Fullam A, Gerstung M, ICGC Prostate Cancer Working Group, ICGC Bone Cancer Working Group, ICGC Breast Cancer Working Group, Nangalia J, Green AR, Caldas C, Borg Å, Tutt A, Lee MT, van't Veer LJ et al. (2015)
    Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells
    Genome Res, 25 (6), 814-24
    PubMed 25963125
  3. Kanojia D, Nagata Y, Garg M, Lee DH, Sato A, Yoshida K, Sato Y, Sanada M, Mayakonda A, Bartenhagen C, Klein HU, Doan NB, Said JW, Mohith S, Gunasekar S, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Myklebost O, Yang H, Dugas M, Meza-Zepeda LA, Silberman AW, Forscher C et al. (2015)
    Genomic landscape of liposarcoma
    Oncotarget, 6 (40), 42429-44
    PubMed 26643872
  4. Myklebost O (2015)
    Personalized cancer therapy for soft tissue sarcomas: progress and pitfalls
    Pers. Med., 12 (6), 593-602
  5. Naderi EH, Skah S, Ugland H, Myklebost O, Sandnes DL, Torgersen ML, Josefsen D, Ruud E, Naderi S, Blomhoff HK (2015)
    Bone marrow stroma-derived PGE2 protects BCP-ALL cells from DNA damage-induced p53 accumulation and cell death
    Mol Cancer, 14, 14
    PubMed 25623255
  6. Rustad EH, Dai HY, Hov H, Coward E, Beisvag V, Myklebost O, Hovig E, Nakken S, Vodák D, Meza-Zepeda LA, Sandvik AK, Wader KF, Misund K, Sundan A, Aarset H, Waage A (2015)
    BRAF V600E mutation in early-stage multiple myeloma: good response to broad acting drugs and no relation to prognosis
    Blood Cancer J, 5, e299
    PubMed 25794135
  7. Serguienko A, Grad I, Wennerstrøm AB, Meza-Zepeda LA, Thiede B, Stratford EW, Myklebost O, Munthe E (2015)
    Metabolic reprogramming of metastatic breast cancer and melanoma by let-7a microRNA
    Oncotarget, 6 (4), 2451-65
    PubMed 25669981

Publications 2014

  1. Barøy T, Kresse SH, Skårn M, Stabell M, Castro R, Lauvrak S, Llombart-Bosch A, Myklebost O, Meza-Zepeda LA (2014)
    Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model
    Mol Cancer, 13, 93
    PubMed 24885297
  2. Chilamakuri CS, Lorenz S, Madoui MA, Vodák D, Sun J, Hovig E, Myklebost O, Meza-Zepeda LA (2014)
    Performance comparison of four exome capture systems for deep sequencing
    BMC Genomics, 15, 449
    PubMed 24912484
  3. Garsed DW, Marshall OJ, Corbin VD, Hsu A, Di Stefano L, Schröder J, Li J, Feng ZP, Kim BW, Kowarsky M, Lansdell B, Brookwell R, Myklebost O, Meza-Zepeda L, Holloway AJ, Pedeutour F, Choo KH, Damore MA, Deans AJ, Papenfuss AT, Thomas DM (2014)
    The architecture and evolution of cancer neochromosomes
    Cancer Cell, 26 (5), 653-67
    PubMed 25517748
  4. Håkelien AM, Bryne JC, Harstad KG, Lorenz S, Paulsen J, Sun J, Mikkelsen TS, Myklebost O, Meza-Zepeda LA (2014)
    The regulatory landscape of osteogenic differentiation
    Stem Cells, 32 (10), 2780-93
    PubMed 24898411
  5. Skårn M, Noordhuis P, Wang MY, Veuger M, Kresse SH, Egeland EV, Micci F, Namløs HM, Håkelien AM, Olafsrud SM, Lorenz S, Haraldsen G, Kvalheim G, Meza-Zepeda LA, Myklebost O (2014)
    Generation and characterization of an immortalized human mesenchymal stromal cell line
    Stem Cells Dev, 23 (19), 2377-89
    PubMed 24857590
  6. Tubio JMC, Martincorena I, Cooke SL, Tojo M, Gundem G, Pipinikas CP, Zamora J, Raine K, Menzies A, Roman-Garcia P, Fullam A, Gerstung M, Shlien A, Tarpey PS, Papaemmanuil E, Knappskog S, Van Loo P, Ramakrishna M, Davies HR, Marshall J, Wedge DC, Teague JW, Butler AP, Nik-Zainal S, Alexandrov L et al. (2014)
    Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes
    Science, 345 (6196), 1251343
    PubMed 25082706
  7. Wennerström AB, Lothe IM, Sandhu V, Kure EH, Myklebost O, Munthe E (2014)
    Generation and characterisation of novel pancreatic adenocarcinoma xenograft models and corresponding primary cell lines
    PLoS One, 9 (8), e103873
    PubMed 25148029

Publications 2013

  1. Bianchini L, Birtwisle L, Saâda E, Bazin A, Long E, Roussel JF, Michiels JF, Forest F, Dani C, Myklebost O, Birtwisle-Peyrottes I, Pedeutour F (2013)
    Identification of PPAP2B as a novel recurrent translocation partner gene of HMGA2 in lipomas
    Genes Chromosomes Cancer, 52 (6), 580-90
    PubMed 23508853
  2. Doorn J, Fernandes HA, Le BQ, van de Peppel J, van Leeuwen JP, De Vries MR, Aref Z, Quax PH, Myklebost O, Saris DB, van Blitterswijk CA, de Boer J (2013)
    A small molecule approach to engineering vascularized tissue
    Biomaterials, 34 (12), 3053-63
    PubMed 23369216
  3. Kuijjer ML, Peterse EF, van den Akker BE, Briaire-de Bruijn IH, Serra M, Meza-Zepeda LA, Myklebost O, Hassan AB, Hogendoorn PC, Cleton-Jansen AM (2013)
    IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma
    BMC Cancer, 13, 245
    PubMed 23688189
  4. Lauvrak SU, Munthe E, Kresse SH, Stratford EW, Namløs HM, Meza-Zepeda LA, Myklebost O (2013)
    Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes
    Br J Cancer, 109 (8), 2228-36
    PubMed 24064976
  5. Nome T, Thomassen GO, Bruun J, Ahlquist T, Bakken AC, Hoff AM, Rognum T, Nesbakken A, Lorenz S, Sun J, Barros-Silva JD, Lind GE, Myklebost O, Teixeira MR, Meza-Zepeda LA, Lothe RA, Skotheim RI (2013)
    Common fusion transcripts identified in colorectal cancer cell lines by high-throughput RNA sequencing
    Transl Oncol, 6 (5), 546-53
    PubMed 24151535
  6. Presneau N, Scheipl S, Pillay N, Van Loo P, Wedge DC, Cooke SL, Gundem G, Davies H, Nik-Zainal S, Martin S, McLaren S, Goodie V, Robinson B, Butler A, Teague JW, Halai D, Khatri B, Myklebost O, Baumhoer D, Jundt G, Hamoudi R, Tirabosco R, Amary MF, Futreal PA, Stratton MR et al. (2013)
    Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone
    Nat Genet, 45 (12), 1479-82
    PubMed 24162739
  7. Sandberg CJ, Altschuler G, Jeong J, Strømme KK, Stangeland B, Murrell W, Grasmo-Wendler UH, Myklebost O, Helseth E, Vik-Mo EO, Hide W, Langmoen IA (2013)
    Comparison of glioma stem cells to neural stem cells from the adult human brain identifies dysregulated Wnt- signaling and a fingerprint associated with clinical outcome
    Exp Cell Res, 319 (14), 2230-43
    PubMed 23791939
  8. Skårn M, Barøy T, Stratford EW, Myklebost O (2013)
    Epigenetic regulation and functional characterization of microRNA-142 in mesenchymal cells
    PLoS One, 8 (11), e79231
    PubMed 24236112
  9. Stratford EW, Bostad M, Castro R, Skarpen E, Berg K, Høgset A, Myklebost O, Selbo PK (2013)
    Photochemical internalization of CD133-targeting immunotoxins efficiently depletes sarcoma cells with stem-like properties and reduces tumorigenicity
    Biochim Biophys Acta, 1830 (8), 4235-43
    PubMed 23643966
  10. Stratford EW, Daffinrud J, Munthe E, Castro R, Waaler J, Krauss S, Myklebost O (2013)
    The tankyrase-specific inhibitor JW74 affects cell cycle progression and induces apoptosis and differentiation in osteosarcoma cell lines
    Cancer Med, 3 (1), 36-46
    PubMed 24403055

Publications 2012

  1. Kresse SH, Rydbeck H, Skårn M, Namløs HM, Barragan-Polania AH, Cleton-Jansen AM, Serra M, Liestøl K, Hogendoorn PC, Hovig E, Myklebost O, Meza-Zepeda LA (2012)
    Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma
    PLoS One, 7 (11), e48262
    PubMed 23144859
  2. Kuijjer ML, Rydbeck H, Kresse SH, Buddingh EP, Lid AB, Roelofs H, Bürger H, Myklebost O, Hogendoorn PC, Meza-Zepeda LA, Cleton-Jansen AM (2012)
    Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data
    Genes Chromosomes Cancer, 51 (7), 696-706
    PubMed 22454324
  3. Namløs HM, Kresse SH, Müller CR, Henriksen J, Holdhus R, Sæter G, Bruland OS, Bjerkehagen B, Steen VM, Myklebost O (2012)
    Global gene expression profiling of human osteosarcomas reveals metastasis-associated chemokine pattern
    Sarcoma, 2012, 639038
    PubMed 22518090
  4. Namløs HM, Meza-Zepeda LA, Barøy T, Østensen IH, Kresse SH, Kuijjer ML, Serra M, Bürger H, Cleton-Jansen AM, Myklebost O (2012)
    Modulation of the osteosarcoma expression phenotype by microRNAs
    PLoS One, 7 (10), e48086
    PubMed 23133552
  5. Ohnstad HO, Castro R, Sun J, Heintz KM, Vassilev LT, Bjerkehagen B, Kresse SH, Meza-Zepeda LA, Myklebost O (2012)
    Correlation of TP53 and MDM2 genotypes with response to therapy in sarcoma
    Cancer, 119 (5), 1013-22
    PubMed 23165797
  6. Skotheim RI, Meza-Zepeda LA, Hovig E, Lønning PE, Lothe RA, Myklebost O (2012)
    [Genome sequencing for personalized cancer treatment]
    Tidsskr Nor Laegeforen, 132 (21), 2406-8
    PubMed 23160594
  7. Stratford EW, Castro R, Daffinrud J, Skårn M, Lauvrak S, Munthe E, Myklebost O (2012)
    Characterization of liposarcoma cell lines for preclinical and biological studies
    Sarcoma, 2012, 148614
    PubMed 22911243

Publications 2011

  1. Buddingh EP, Kuijjer ML, Duim RA, Bürger H, Agelopoulos K, Myklebost O, Serra M, Mertens F, Hogendoorn PC, Lankester AC, Cleton-Jansen AM (2011)
    Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents
    Clin Cancer Res, 17 (8), 2110-9
    PubMed 21372215
  2. Hjortland GO, Meza-Zepeda LA, Beiske K, Ree AH, Tveito S, Hoifodt H, Bohler PJ, Hole KH, Myklebost O, Fodstad O, Smeland S, Hovig E (2011)
    Genome wide single cell analysis of chemotherapy resistant metastatic cells in a case of gastroesophageal adenocarcinoma
    BMC Cancer, 11, 455
    PubMed 22014070
  3. Kresse SH, Meza-Zepeda LA, Machado I, Llombart-Bosch A, Myklebost O (2011)
    Preclinical xenograft models of human sarcoma show nonrandom loss of aberrations
    Cancer, 118 (2), 558-70
    PubMed 21713766
  4. Kuijjer ML, Namløs HM, Hauben EI, Machado I, Kresse SH, Serra M, Llombart-Bosch A, Hogendoorn PC, Meza-Zepeda LA, Myklebost O, Cleton-Jansen AM (2011)
    mRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenografts
    BMC Med Genomics, 4, 66
    PubMed 21933437
  5. Ohnstad HO, Paulsen EB, Noordhuis P, Berg M, Lothe RA, Vassilev LT, Myklebost O (2011)
    MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines
    BMC Cancer, 11, 211:1-11
    PubMed 21624110
  6. Skårn M, Namløs HM, Noordhuis P, Wang MY, Meza-Zepeda LA, Myklebost O (2011)
    Adipocyte differentiation of human bone marrow-derived stromal cells is modulated by microRNA-155, microRNA-221, and microRNA-222
    Stem Cells Dev, 21 (6), 873-83
    PubMed 21756067
  7. Stratford EW, Castro R, Wennerstrom A, Holm R, Munthe E, Lauvrak S, Bjerkehagen B, Myklebost O (2011)
    Liposarcoma Cells with Aldefluor and CD133 Activity have a Cancer Stem Cell Potential
    Clin Sarcoma Res, 1 (1), 8
    PubMed 22612877
  8. Thomas DM, Wilhelm M, Cleton-Jansen AM, Dirksen U, Entz-Werlé N, Gelderblom H, Hassan B, Jürgens H, Koster J, Kovar H, Lankester AC, Lewis IJ, Myklebost O, Nathrath MH, Picci P, Whelan JS, Hogendoorn PC, Bielack SS (2011)
    Workshop Report on the European Bone Sarcoma Networking Meeting: Integration of Clinical Trials with Tumor Biology
    J Adolesc Young Adult Oncol, 1 (3), 118-23
    PubMed 26811922

Publications 2010

  1. Eide MB, Liestøl K, Lingjaerde OC, Hystad ME, Kresse SH, Meza-Zepeda L, Myklebost O, Trøen G, Aamot HV, Holte H, Smeland EB, Delabie J (2010)
    Genomic alterations reveal potential for higher grade transformation in follicular lymphoma and confirm parallel evolution of tumor cell clones
    Blood, 116 (9), 1489-97
    PubMed 20505157
  2. Henriksen J, Stabell M, Meza-Zepeda LA, Lauvrak SA, Kassem M, Myklebost O (2010)
    Identification of target genes for wild type and truncated HMGA2 in mesenchymal stem-like cells
    BMC Cancer, 10, 329
    PubMed 20576167
  3. Kresse SH, Ohnstad HO, Bjerkehagen B, Myklebost O, Meza-Zepeda LA (2010)
    DNA copy number changes in human malignant fibrous histiocytomas by array comparative genomic hybridisation
    PLoS One, 5 (11), e15378
    PubMed 21085701
  4. Kresse SH, Szuhai K, Barragan-Polania AH, Rydbeck H, Cleton-Jansen AM, Myklebost O, Meza-Zepeda LA (2010)
    Evaluation of high-resolution microarray platforms for genomic profiling of bone tumours
    BMC Res Notes, 3, 223
    PubMed 20691109
  5. Mayordomo E, Machado I, Giner F, Kresse SH, Myklebost O, Carda C, Navarro S, Llombart-Bosch A (2010)
    A tissue microarray study of osteosarcoma: histopathologic and immunohistochemical validation of xenotransplanted tumors as preclinical models
    Appl Immunohistochem Mol Morphol, 18 (5), 453-61
    PubMed 20436344
  6. Ottaviano L, Schaefer KL, Gajewski M, Huckenbeck W, Baldus S, Rogel U, Mackintosh C, de Alava E, Myklebost O, Kresse SH, Meza-Zepeda LA, Serra M, Cleton-Jansen AM, Hogendoorn PC, Buerger H, Aigner T, Gabbert HE, Poremba C (2010)
    Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effort
    Genes Chromosomes Cancer, 49 (1), 40-51
    PubMed 19787792
  7. Tenstad E, Tourovskaia A, Folch A, Myklebost O, Rian E (2010)
    Extensive adipogenic and osteogenic differentiation of patterned human mesenchymal stem cells in a microfluidic device
    Lab Chip, 10 (11), 1401-1409
    PubMed 20386793

Publications 2009

  1. Kresse SH, Ohnstad HO, Paulsen EB, Bjerkehagen B, Szuhai K, Serra M, Schaefer KL, Myklebost O, Meza-Zepeda LA (2009)
    LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization
    Genes Chromosomes Cancer, 48 (8), 679-93
    PubMed 19441093
  2. Lehne G, Grasmo-Wendler UH, Berner JM, Meza-Zepeda LA, Adamsen BL, Flack A, Reiner A, Clausen OP, Hovig E, Myklebost O (2009)
    Upregulation of stem cell genes in multidrug resistant K562 leukemia cells
    Leuk Res, 33 (10), 1379-85
    PubMed 19394083
  3. Myklebost O, Noordhuis P (2009)
    Bone marrow stroma cells regulate TIEG1 expression in acute lymphoblastic leukemia cells: Role of TGF beta/BMP-6 and TIEG1 in chemotherapy escape. (vol 123, pg 2759, 2008)
    Int. J. Cancer, 124 (9), 2250

Publications 2008

  1. Kresse SH, Skårn M, Ohnstad HO, Namløs HM, Bjerkehagen B, Myklebost O, Meza-Zepeda LA (2008)
    DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH
    Mol Cancer, 7, 48
    PubMed 18522746
  2. Lyng H, Lando M, Brøvig RS, Svendsrud DH, Johansen M, Galteland E, Brustugun OT, Meza-Zepeda LA, Myklebost O, Kristensen GB, Hovig E, Stokke T (2008)
    GeneCount: genome-wide calculation of absolute tumor DNA copy numbers from array comparative genomic hybridization data
    Genome Biol, 9 (5), R86
    PubMed 18500990
  3. Meza-Zepeda LA, Noer A, Dahl JA, Micci F, Myklebost O, Collas P (2008)
    High-resolution analysis of genetic stability of human adipose tissue stem cells cultured to senescence
    J Cell Mol Med, 12 (2), 553-63
    PubMed 18419597
  4. Roman E, Meza-Zepeda LA, Kresse SH, Myklebost O, Vasstrand EN, Ibrahim SO (2008)
    Chromosomal aberrations in head and neck squamous cell carcinomas in Norwegian and Sudanese populations by array comparative genomic hybridization
    Oncol Rep, 20 (4), 825-43
    PubMed 18813824

Publications 2007

  1. Francis P, Namløs HM, Müller C, Edén P, Fernebro J, Berner JM, Bjerkehagen B, Akerman M, Bendahl PO, Isinger A, Rydholm A, Myklebost O, Nilbert M (2007)
    Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential
    BMC Genomics, 8, 73
    PubMed 17359542
  2. Kleivi K, Lind GE, Diep CB, Meling GI, Brandal LT, Nesland JM, Myklebost O, Rognum TO, Giercksky KE, Skotheim RI, Lothe RA (2007)
    Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses
    Mol Cancer, 6, 2
    PubMed 17201907
  3. Müller CR, Paulsen EB, Noordhuis P, Pedeutour F, Saeter G, Myklebost O (2007)
    Potential for treatment of liposarcomas with the MDM2 antagonist Nutlin-3A
    Int J Cancer, 121 (1), 199-205
    PubMed 17354236

Publications 2006

  1. Berner JM, Muller CR, Holden M, Wang J, Hovig E, Myklebost O (2006)
    Sampling effects on gene expression data from a human tumour xenograft
    Scand. J. Lab. Anim. Sci., 33 (1), 17-30
  2. MAQC Consortium, Shi L, Reid LH, Jones WD, Shippy R, Warrington JA, Baker SC, Collins PJ, de Longueville F, Kawasaki ES, Lee KY, Luo Y, Sun YA, Willey JC, Setterquist RA, Fischer GM, Tong W, Dragan YP, Dix DJ, Frueh FW, Goodsaid FM, Herman D, Jensen RV, Johnson CD, Lobenhofer EK et al. (2006)
    The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements
    Nat Biotechnol, 24 (9), 1151-61
    PubMed 16964229
  3. Meza-Zepeda LA, Kresse SH, Barragan-Polania AH, Bjerkehagen B, Ohnstad HO, Namløs HM, Wang J, Kristiansen BE, Myklebost O (2006)
    Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas
    Cancer Res, 66 (18), 8984-93
    PubMed 16982739
  4. Sivertsen EA, Galteland E, Mu D, Holte H, Meza-Zepeda L, Myklebost O, Patzke S, Smeland EB, Stokke T (2006)
    Gain of chromosome 6p is an infrequent cause of increased PIM1 expression in B-cell non-Hodgkin's lymphomas
    Leukemia, 20 (3), 539-42
    PubMed 16437153
  5. Tovar C, Rosinski J, Filipovic Z, Higgins B, Kolinsky K, Hilton H, Zhao X, Vu BT, Qing W, Packman K, Myklebost O, Heimbrook DC, Vassilev LT (2006)
    Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy
    Proc Natl Acad Sci U S A, 103 (6), 1888-93
    PubMed 16443686

Publications 2005

  1. Agesen TH, Flørenes VA, Molenaar WM, Lind GE, Berner JM, Plaat BE, Komdeur R, Myklebost O, van den Berg E, Lothe RA (2005)
    Expression patterns of cell cycle components in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors
    J Neuropathol Exp Neurol, 64 (1), 74-81
    PubMed 15715087
  2. Bjerkehagen B, Myklebost O (2005)
    [Molecular genetics in the diagnosis of bone and soft tissue tumours]
    Tidsskr Nor Laegeforen, 125 (23), 3286-9
    PubMed 16327856
  3. Galteland E, Sivertsen EA, Svendsrud DH, Smedshammer L, Kresse SH, Meza-Zepeda LA, Myklebost O, Suo Z, Mu D, Deangelis PM, Stokke T (2005)
    Translocation t(14;18) and gain of chromosome 18/BCL2: effects on BCL2 expression and apoptosis in B-cell non-Hodgkin's lymphomas
    Leukemia, 19 (12), 2313-23
    PubMed 16193090
  4. Kresse SH, Berner JM, Meza-Zepeda LA, Gregory SG, Kuo WL, Gray JW, Forus A, Myklebost O (2005)
    Mapping and characterization of the amplicon near APOA2 in 1q23 in human sarcomas by FISH and array CGH
    Mol Cancer, 4, 39
    PubMed 16274472
  5. Lyng H, Landsverk KS, Kristiansen E, DeAngelis PM, Ree AH, Myklebost O, Hovig E, Stokke T (2005)
    Response of malignant B lymphocytes to ionizing radiation: gene expression and genotype
    Int J Cancer, 115 (6), 935-42
    PubMed 15723354
  6. Nygaard V, Holden M, Løland A, Langaas M, Myklebost O, Hovig E (2005)
    Limitations of mRNA amplification from small-size cell samples
    BMC Genomics, 6, 147
    PubMed 16253144

Publications 2004

  1. Cekaite L, Haug O, Myklebost O, Aldrin M, Østenstad B, Holden M, Frigessi A, Hovig E, Sioud M (2004)
    Analysis of the humoral immune response to immunoselected phage-displayed peptides by a microarray-based method
    Proteomics, 4 (9), 2572-82
    PubMed 15352232
  2. Lyng H, Badiee A, Svendsrud DH, Hovig E, Myklebost O, Stokke T (2004)
    Profound influence of microarray scanner characteristics on gene expression ratios: analysis and procedure for correction
    BMC Genomics, 5 (1), 10
    PubMed 15018648
  3. Myklebost O (2004)
    Putting Norway on the gene-therapy map
    Nature, 429 (6988), 129
    PubMed 15141186
  4. Nilbert M, Meza-Zepeda LA, Francis P, Berner JM, Namløs HM, Fernebro J, Myklebost O (2004)
    Lessons from genetic profiling in soft tissue sarcomas
    Acta Orthop Scand Suppl, 75 (311), 35-50
    PubMed 15188664
  5. Nilsson M, Meza-Zepeda LA, Mertens F, Forus A, Myklebost O, Mandahl N (2004)
    Amplification of chromosome 1 sequences in lipomatous tumors and other sarcomas
    Int J Cancer, 109 (3), 363-9
    PubMed 14961574
  6. Trøen G, Nygaard V, Jenssen TK, Ikonomou IM, Tierens A, Matutes E, Gruszka-Westwood A, Catovsky D, Myklebost O, Lauritzsen G, Hovig E, Delabie J (2004)
    Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma
    J Mol Diagn, 6 (4), 297-307
    PubMed 15507668
  7. Wang J, Meza-Zepeda LA, Kresse SH, Myklebost O (2004)
    M-CGH: analysing microarray-based CGH experiments
    BMC Bioinformatics, 5, 74
    PubMed 15189572

Publications 2003

  1. Andersen K, Smith-Sørensen B, Pedersen KB, Hovig E, Myklebost O, Fodstad Ø, Maelandsmo GM (2003)
    Interferon-gamma suppresses S100A4 transcription independently of apoptosis or cell cycle arrest
    Br J Cancer, 88 (12), 1995-2001
    PubMed 12799648
  2. Henriksen J, Aagesen TH, Maelandsmo GM, Lothe RA, Myklebost O, Forus A (2003)
    Amplification and overexpression of COPS3 in osteosarcomas potentially target TP53 for proteasome-mediated degradation
    Oncogene, 22 (34), 5358-61
    PubMed 12917637
  3. Maire G, Forus A, Foa C, Bjerkehagen B, Mainguené C, Kresse SH, Myklebost O, Pedeutour F (2003)
    11q13 alterations in two cases of hibernoma: large heterozygous deletions and rearrangement breakpoints near GARP in 11q13.5
    Genes Chromosomes Cancer, 37 (4), 389-95
    PubMed 12800150
  4. Nygaard V, Løland A, Holden M, Langaas M, Rue H, Liu F, Myklebost O, Fodstad Ø, Hovig E, Smith-Sørensen B (2003)
    Effects of mRNA amplification on gene expression ratios in cDNA experiments estimated by analysis of variance
    BMC Genomics, 4 (1), 11
    PubMed 12659661
  5. Wang J, Bø TH, Jonassen I, Myklebost O, Hovig E (2003)
    Tumor classification and marker gene prediction by feature selection and fuzzy c-means clustering using microarray data
    BMC Bioinformatics, 4, 60
    PubMed 14651757
  6. Wang J, Myklebost O, Hovig E (2003)
    MGraph: graphical models for microarray data analysis
    Bioinformatics, 19 (17), 2210-1
    PubMed 14630649

Publications 2002

  1. Jenssen TK, Langaas M, Kuo WP, Smith-Sørensen B, Myklebost O, Hovig E (2002)
    Analysis of repeatability in spotted cDNA microarrays
    Nucleic Acids Res, 30 (14), 3235-44
    PubMed 12136105
  2. Meza-Zepeda LA, Forus A, Lygren B, Dahlberg AB, Godager LH, South AP, Marenholz I, Lioumi M, Flørenes VA, Maelandsmo GM, Serra M, Mischke D, Nizetic D, Ragoussis J, Tarkkanen M, Nesland JM, Knuutila S, Myklebost O (2002)
    Positional cloning identifies a novel cyclophilin as a candidate amplified oncogene in 1q21
    Oncogene, 21 (14), 2261-9
    PubMed 11948409
  3. Wang J, Delabie J, Aasheim H, Smeland E, Myklebost O (2002)
    Clustering of the SOM easily reveals distinct gene expression patterns: results of a reanalysis of lymphoma study
    BMC Bioinformatics, 3, 36
    PubMed 12445336
  4. Wang J, Nygaard V, Smith-Sørensen B, Hovig E, Myklebost O (2002)
    MArray: analysing single, replicated or reversed microarray experiments
    Bioinformatics, 18 (8), 1139-40
    PubMed 12176840
  5. Xie Y, Skytting B, Nilsson G, Grimer RJ, Mangham CD, Fisher C, Shipley J, Bjerkehagen B, Myklebost O, Larsson O (2002)
    The SYT-SSX1 fusion type of synovial sarcoma is associated with increased expression of cyclin A and D1. A link between t(X;18)(p11.2; q11.2) and the cell cycle machinery
    Oncogene, 21 (37), 5791-6
    PubMed 12173050

Publications 2001

  1. Forus A, Bjerkehagen B, Sirvent N, Meza-Zepeda LA, Coindre JM, Berner JM, Myklebost O, Pedeutour F (2001)
    A well-differentiated liposarcoma with a new type of chromosome 12-derived markers
    Cancer Genet Cytogenet, 131 (1), 13-8
    PubMed 11734312
  2. Forus A, D'Angelo A, Henriksen J, Merla G, Maelandsmo GM, Flørenes VA, Olivieri S, Bjerkehagen B, Meza-Zepeda LA, del Vecchio Blanco F, Müller C, Sanvito F, Kononen J, Nesland JM, Fodstad Ø, Reymond A, Kallioniemi OP, Arrigoni G, Ballabio A, Myklebost O, Zollo M (2001)
    Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas-a possible mechanism for altering the nm23-H1 activity
    Oncogene, 20 (47), 6881-90
    PubMed 11687967
  3. Forus A, Larramendy ML, Meza-Zepeda LA, Bjerkehagen B, Godager LH, Dahlberg AB, Saeter G, Knuutila S, Myklebost O (2001)
    Dedifferentiation of a well-differentiated liposarcoma to a highly malignant metastatic osteosarcoma: amplification of 12q14 at all stages and gain of 1q22-q24 associated with metastases
    Cancer Genet Cytogenet, 125 (2), 100-11
    PubMed 11369052
  4. Forus A, Sørlie T, Børresen-Dale AL, Myklebost O (2001)
    [Microarray technology--potential in cancer research]
    Tidsskr Nor Laegeforen, 121 (21), 2498-503
    PubMed 11875927
  5. Hovig E, Myklebost O, Aamdal S, Smeland EB (2001)
    [Gene therapy in cancer]
    Tidsskr Nor Laegeforen, 121 (4), 482-8
    PubMed 11255868
  6. Meza-Zepeda LA, Berner JM, Henriksen J, South AP, Pedeutour F, Dahlberg AB, Godager LH, Nizetic D, Forus A, Myklebost O (2001)
    Ectopic sequences from truncated HMGIC in liposarcomas are derived from various amplified chromosomal regions
    Genes Chromosomes Cancer, 31 (3), 264-73
    PubMed 11391797
  7. Sandvik AK, Støren O, Nørsett K, Laegreid A, Børresen-Dale AL, Myklebost O (2001)
    [Measurement of gene activity by DNA microarrays]
    Tidsskr Nor Laegeforen, 121 (10), 1225-8
    PubMed 11402749

Publications 2000

  1. Simons A, Schepens M, Jeuken J, Sprenger S, van de Zande G, Bjerkehagen B, Forus A, Weibolt V, Molenaar I, van den Berg E, Myklebost O, Bridge J, van Kessel AG, Suijkerbuijk R (2000)
    Frequent loss of 9p21 (p16(INK4A)) and other genomic imbalances in human malignant fibrous histiocytoma
    Cancer Genet Cytogenet, 118 (2), 89-98
    PubMed 10748288
  2. Sirvent N, Forus A, Lescaut W, Burel F, Benzaken S, Chazal M, Bourgeon A, Vermeesch JR, Myklebost O, Turc-Carel C, Ayraud N, Coindre JM, Pedeutour F (2000)
    Characterization of centromere alterations in liposarcomas
    Gene Chromosomes Cancer, 29 (2), 117-129

Publications 1999

  1. Berner JM, Sørlie T, Mertens F, Henriksen J, Saeter G, Mandahl N, Brøgger A, Myklebost O, Lothe RA (1999)
    Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumors: studies of CDKN2A and other genes of the pRB pathway
    Genes Chromosomes Cancer, 26 (2), 151-60
    PubMed 10469453
  2. Forus A, Høifødt HK, Overli GE, Myklebost O, Fodstad O (1999)
    Sensitive fluorescent in situ hybridisation method for the characterisation of breast cancer cells in bone marrow aspirates
    Mol Pathol, 52 (2), 68-74
    PubMed 10474684
  3. Pedeutour F, Forus A, Coindre JM, Berner JM, Nicolo G, Michiels JF, Terrier P, Ranchere-Vince D, Collin F, Myklebost O, Turc-Carel C (1999)
    Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors
    Gene Chromosomes Cancer, 24 (1), 30-41
  4. Simons A, Schepens M, Forus A, Godager L, van Asseldonk M, Myklebost O, van Kessel AG (1999)
    A novel chromosomal region of allelic loss, 4q32-q34, in human osteosarcomas revealed by representational difference analysis
    Gene Chromosomes Cancer, 26 (2), 115-124
  5. Wolf M, Tarkkanen M, Hulsebos T, Larramendy ML, Forus A, Myklebost O, Aaltonen LA, Elomaa I, Knuutila S (1999)
    Characterization of the 17p amplicon in human sarcomas : Microsatellite marker analysis
    Int. J. Cancer, 82 (3), 329-333

Publications 1998

  1. Forus A, Berner JM, Meza-Zepeda LA, Saeter G, Mischke D, Fodstad O, Myklebost O (1998)
    Molecular characterization of a novel amplicon at 1q21-q22 frequently observed in human sarcomas
    Br J Cancer, 78 (4), 495-503
    PubMed 9716033
  2. Myklebost O (1998)
    GLI gene and rhabdomyosarcoma
    Nat. Med., 4 (8), 869

Publications 1997

  1. Armengol G, Tarkkanen M, Virolainen M, Forus A, Valle J, Böhling T, Asko-Seljavaara S, Blomqvist C, Elomaa I, Karaharju E, Kivioja AH, Siimes MA, Tukiainen E, Caballín MR, Myklebost O, Knuutila S (1997)
    Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridization
    Br J Cancer, 75 (10), 1403-9
    PubMed 9166930
  2. Berner JM, Meza-Zepeda LA, Kools PF, Forus A, Schoenmakers EF, Van de Ven WJ, Fodstad O, Myklebost O (1997)
    HMGIC, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas
    Oncogene, 14 (24), 2935-41
    PubMed 9205100
  3. Geurts van Kessel A, dos Santos NR, Simons A, de Bruijn D, Forus A, Fodstad O, Myklebost O, Balemans M, Baats E, Olde Weghuis D, Suijkerbuijk RF, van den Berg E, Molenaar WM, de Leeuw B (1997)
    Molecular cytogenetics of bone and soft tissue tumors
    Cancer Genet Cytogenet, 95 (1), 67-73
    PubMed 9140455
  4. vanKessel AG, dosSantos NR, Simons A, deBruijn D, Forus A, Fodstad O, Myklebost O, Balemans M, Baats E, Weghuis DO, Suijkerbuijk RF, vandenBerg E, Molenaar WM, deLeeuw B (1997)
    Molecular cytogenetics of bone and soft tissue tumors
    Cancer Genet. Cytogenet., 95 (1), 67-73
  5. Wolf M, Aaltonen LA, Szymanska J, Tarkkanen M, Blomqvist C, Berner JM, Myklebost O, Knuutila S (1997)
    Complexity of 12q13-22 amplicon in liposarcoma: Microsatellite repeat analysis
    Gene Chromosomes Cancer, 18 (1), 66-70

Publications 1996

  1. Berner JM, Forus A, Elkahloun A, Meltzer PS, Fodstad O, Myklebost O (1996)
    Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas
    Genes Chromosomes Cancer, 17 (4), 254-9
    PubMed 8946207
  2. Maelandsmo GM, Hovig E, Skrede M, Engebraaten O, Flørenes VA, Myklebost O, Grigorian M, Lukanidin E, Scanlon KJ, Fodstad O (1996)
    Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme
    Cancer Res, 56 (23), 5490-8
    PubMed 8968106

Publications 1995

  1. Forus A, Weghuis DO, Smeets D, Fodstad O, Myklebost O, Geurts van Kessel A (1995)
    Comparative genomic hybridization analysis of human sarcomas: II. Identification of novel amplicons at 6p and 17p in osteosarcomas
    Genes Chromosomes Cancer, 14 (1), 15-21
    PubMed 8527379
  2. Forus A, Weghuis DO, Smeets D, Fodstad O, Myklebost O, van Kessel AG (1995)
    Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas
    Genes Chromosomes Cancer, 14 (1), 8-14
    PubMed 8527390
  3. Kulseth MA, Krajci P, Myklebost O, Rogne S (1995)
    Cloning and characterization of two forms of bovine polymeric immunoglobulin receptor cDNA
    DNA Cell Biol, 14 (3), 251-6
    PubMed 7880445
  4. Maelandsmo GM, Berner JM, Flørenes VA, Forus A, Hovig E, Fodstad O, Myklebost O (1995)
    Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas--relationship to amplification and mRNA levels of CDK4 and CCND1
    Br J Cancer, 72 (2), 393-8
    PubMed 7640224
  5. Van Roy N, Forus A, Myklebost O, Cheng NC, Versteeg R, Speleman F (1995)
    Identification of two distinct chromosome 12-derived amplification units in neuroblastoma cell line NGP
    Cancer Genet Cytogenet, 82 (2), 151-4
    PubMed 7664245

Publications 1994

  1. Flørenes VA, Holm R, Myklebost O, Lendahl U, Fodstad O (1994)
    Expression of the neuroectodermal intermediate filament nestin in human melanomas
    Cancer Res, 54 (2), 354-6
    PubMed 8275467
  2. Flørenes VA, Maelandsmo GM, Forus A, Andreassen A, Myklebost O, Fodstad O (1994)
    MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status
    J Natl Cancer Inst, 86 (17), 1297-302
    PubMed 8064888
  3. Forus A, Flørenes VA, Maelandsmo GM, Fodstad O, Myklebost O (1994)
    The protooncogene CHOP/GADD153, involved in growth arrest and DNA damage response, is amplified in a subset of human sarcomas
    Cancer Genet Cytogenet, 78 (2), 165-71
    PubMed 7828148
  4. Forus A, Kools PF, Schoenmakers EF, Van de Ven WJ, Myklebost O (1994)
    A long range restriction map spanning the myxoid liposarcoma breakpoint in the q13-14 region of human chromosome 12
    Hum Genet, 94 (3), 259-64
    PubMed 8076941
  5. Suijkerbuijk RF, Olde Weghuis DE, Van den Berg M, Pedeutour F, Forus A, Myklebost O, Glier C, Turc-Carel C, Geurts van Kessel A (1994)
    Comparative genomic hybridization as a tool to define two distinct chromosome 12-derived amplification units in well-differentiated liposarcomas
    Genes Chromosomes Cancer, 9 (4), 292-5
    PubMed 7519052

Publications 1993

  1. ANDREASSEN A, BORRESEN AL, OYJORD T, SOLHEIM OP, FLORENES VA, BRULAND O, MYKLEBOST O, HOIE J, FODSTAD O (1993)
    CHROMOSOME-17P ABERRATIONS AND P53 EXPRESSION IN HUMAN SARCOMAS
    FRONTIERS OF OSTEOSARCOMA RESEARCH: INTERDISCIPLINARY SURVEY OF CLINICAL AND RESEARCH ADVANCES, 419-422
  2. Andreassen A, Oyjord T, Hovig E, Holm R, Flørenes VA, Nesland JM, Myklebost O, Høie J, Bruland OS, Børresen AL (1993)
    p53 abnormalities in different subtypes of human sarcomas
    Cancer Res, 53 (3), 468-71
    PubMed 8425179
  3. Brzozowska A, Fries R, Womack JE, Grimholt U, Myklebost O, Rogne S (1993)
    Isolation, sequencing, and expression analysis of a bovine apolipoprotein E (APOE) cDNA and chromosomal localization of the APOE locus
    Mamm Genome, 4 (1), 53-7
    PubMed 8422503
  4. Forus A, Flørenes VA, Maelandsmo GM, Meltzer PS, Fodstad O, Myklebost O (1993)
    Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: some amplica do not include MDM2
    Cell Growth Differ, 4 (12), 1065-70
    PubMed 8117620

Publications 1992

  1. Flørenes VA, Aamdal S, Myklebost O, Maelandsmo GM, Bruland OS, Fodstad O (1992)
    Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression
    Cancer Res, 52 (21), 6088-91
    PubMed 1356624
  2. Forus A, Myklebost O (1992)
    A physical map of a 1.3-Mb region on the long arm of chromosome 12, spanning the GLI and LRP loci
    Genomics, 14 (1), 117-20
    PubMed 1427818
  3. Skrede B, Blomhoff R, Maelandsmo GM, Ose L, Myklebost O, Norum KR (1992)
    Uptake of chylomicron remnant retinyl esters in human leukocytes in vivo
    Eur J Clin Invest, 22 (4), 229-34
    PubMed 1499639

Publications 1991

  1. Rogne S, Myklebost O, Olving JH, Kyrkjebø HT, Jonassen R, Olaisen B, Gedde-Dahl T (1991)
    The human genes for complement components 6 (C6) and 9 (C9) are closely linked on chromosome 5
    J Med Genet, 28 (9), 587-90
    PubMed 1683409

Publications 1990

  1. Myklebost O, Rogne S, Hjermann I, Olaisen B, Prydz H (1990)
    Association analysis of lipid levels and apolipoprotein restriction fragment length polymorphisms
    Hum Genet, 86 (2), 209-14
    PubMed 1979958
  2. Rogne S, Mevåg B, Gedde-Dahl T, Myklebost O (1990)
    Multiple RFLPs of human complement component nine (C9) detected by TaqI
    Nucleic Acids Res, 18 (10), 3112
    PubMed 1971940

Publications 1989

  1. Myklebost O, Arheden K, Rogne S, Geurts van Kessel A, Mandahl N, Herz J, Stanley K, Heim S, Mitelman F (1989)
    The gene for the human putative apoE receptor is on chromosome 12 in the segment q13-14
    Genomics, 5 (1), 65-9
    PubMed 2548950
  2. Nenseter MS, Myklebost O, Blomhoff R, Drevon CA, Nilsson A, Norum KR, Berg T (1989)
    Low-density-lipoprotein receptors in different rabbit liver cells
    Biochem J, 261 (2), 587-93
    PubMed 2549976
  3. Rogne S, Myklebost O, Høyheim B, Olaisen B, Gedde-Dahl T (1989)
    The genes for apolipoprotein all (APOA2) and the Duffy blood group (FY) are linked on chromosome 1 in man
    Genomics, 4 (2), 169-73
    PubMed 2500391

Publications 1988

  1. Herz J, Hamann U, Rogne S, Myklebost O, Gausepohl H, Stanley KK (1988)
    Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor
    EMBO J, 7 (13), 4119-27
    PubMed 3266596
  2. Myklebost O, Rogne S (1988)
    A physical map of the apolipoprotein gene cluster on human chromosome 19
    Hum Genet, 78 (3), 244-7
    PubMed 2894348

Publications 1987

  1. Rogne S, Skretting G, Larsen F, Myklebost O, Mevåg B, Carlson LA, Holmquist L, Gjone E, Prydz H (1987)
    The isolation and characterisation of a cDNA clone for human lecithin:cholesterol acyl transferase and its use to analyse the genes in patients with LCAT deficiency and fish eye disease
    Biochem Biophys Res Commun, 148 (1), 161-9
    PubMed 2823801

Publications 1986

  1. Myklebost O, Rogne S (1986)
    The gene for human apolipoprotein CI is located 4.3 kilobases away from the apolipoprotein E gene on chromosome 19
    Hum Genet, 73 (4), 286-9
    PubMed 3017837
  2. Rogne S, Myklebost O, Olaisen B, Gedde-Dahl T, Prydz H (1986)
    Confirmation of the close linkage between the loci for human apolipoproteins AI and AIV by the use of a cloned cDNA probe and two restriction site polymorphisms
    Hum Genet, 72 (1), 68-71
    PubMed 3002953

Publications 1985

  1. Rogne S, Rønning OW, Myklebost O, Seglen PO, Pettersen EO (1985)
    Cell cycle traverse and protein metabolism in human NHIK 3025 cells: the role of anchorage
    J Cell Physiol, 125 (3), 528-32
    PubMed 4066771

Publications 1984

  1. Myklebost O, Rogne S, Olaisen B, Gedde-Dahl T, Prydz H (1984)
    The locus for apolipoprotein CII is closely linked to the apolipoprotein E locus on chromosome 19 in man
    Hum Genet, 67 (3), 309-12
    PubMed 6088388